Back to resultsEffect of Dry Needling on Surface Electromyographic Activity in Latent Trigger Points
Primary Purpose
Trigger Point Pain, Myofascial
Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Intervention-Dry Needling
Control-Dry Needling
Sponsored by
About this trial
This is an interventional treatment trial for Trigger Point Pain, Myofascial focused on measuring Dry needling, Electromyography, Latent trigger point
Eligibility Criteria
Inclusion Criteria:
- Age between 18 and 30 years
- The presence of LTrP in the middle third of the upper trapezius muscle onthe dominant side
- Being able to provide written informed consent
- Being able to follow instructions and realize clinical tests
Exclusion Criteria:
- Any pharmacological therapeutic
- Any medical treatment or physical therapies at cervical region during the 6-month before this study
- Any diagnosed health problem
- Any history of head and upper extremity surgery or trauma
- Any red flags to DN, (ie: metabolic diseases, pregnancy, kinesiophobia,Infection, cancer)• Absence of recurrent history of neck pain
- No neck pain symptomatology the previous 6 months
- Cervical disk herniation
Sites / Locations
- Performance and Sport Rehabilitation Laboratory
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
Deep Dry Needling
Sham Dry Needling
Arm Description
Intervention-Dry Needling: Deep Dry Needing into the latent trigger point of the upper trapezius muscle
Control-Dry Needling: Sham Dry Needling into the latent trigger point of the upper trapezius muscle
Outcomes
Primary Outcome Measures
Changes in resting surface EMG activity (amplitude, RMS)
EMG activity (RMS) of the upper trapezius after dry needling or sham needling as assessed by the EMG ME 6000 TE(Mega Electronics, Kuopio, Finland). Resting EMG activity will be expressed as a percentage of maximal reference contractions of the upper trapezius (% reference contractions).
Secondary Outcome Measures
Changes in resting surface EMG activity (Median frequency, MF)
EMG activity (RMS) of the upper trapezius after dry needling or sham needling as assessed by the EMG ME 6000 TE(Mega Electronics, Kuopio, Finland).
EMG median frequency will be used to determine the endurance of the upper trapezius. The EMG median frequency will be measured in Hertz (Hz).
Changes in submaximal contrations surface EMG activity of upper trapezius (amplitude, RMS)
EMG activity (RMS) of the upper trapezius after dry needling or sham needling as assessed by the EMG ME 6000 TE(Mega Electronics, Kuopio, Finland).
EMG activity of submaximal contractions will be expressed as a percentage of submaximal reference contractions of the upper trapezius (% reference contractions).
Changes in submaximal contrations surface EMG activity of upper trapezius (Median frequency, MF)
EMG activity (RMS) of the upper trapezius after dry needling or sham needling as assessed by the EMG ME 6000 TE(Mega Electronics, Kuopio, Finland).
EMG median frequency will be used to determine the endurance of the upper trapezius. The EMG median frequency will be measured in Hertz (Hz).
Change in Pain Pressure Threshold (PPT)
Pressure-Pain Threshold as assessed by an manual mechanical algometer. PPT is the minimal amount of pressure that produces pain and is used to assess abnormalities in nociceptive processing or hyperalgesia.
Full Information
NCT ID
NCT04684784
First Posted
December 21, 2020
Last Updated
February 18, 2021
Sponsor
University of Castilla-La Mancha
1. Study Identification
Unique Protocol Identification Number
NCT04684784
Brief Title
Effect of Dry Needling on Surface Electromyographic Activity in Latent Trigger Points
Official Title
Effect of Dry Needling on Surface Electromyographic Activity in Latent Trigger Points
Study Type
Interventional
2. Study Status
Record Verification Date
December 2020
Overall Recruitment Status
Completed
Study Start Date
January 4, 2021 (Actual)
Primary Completion Date
February 4, 2021 (Actual)
Study Completion Date
February 18, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Castilla-La Mancha
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Brief summary: The purpose of this study is to determine the effect of Dry Needling (DN) on electromyographic activity in different situations at the latent trigger point (LTrP) point of the upper trapezius. Randomized controlled trial, in parallel with the crossover control design. Two groups with LTrP in the upper trapezius, and the DN group or the Sham-Dn group will be randomly selected.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Trigger Point Pain, Myofascial
Keywords
Dry needling, Electromyography, Latent trigger point
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
46 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Deep Dry Needling
Arm Type
Experimental
Arm Description
Intervention-Dry Needling: Deep Dry Needing into the latent trigger point of the upper trapezius muscle
Arm Title
Sham Dry Needling
Arm Type
Placebo Comparator
Arm Description
Control-Dry Needling: Sham Dry Needling into the latent trigger point of the upper trapezius muscle
Intervention Type
Device
Intervention Name(s)
Intervention-Dry Needling
Intervention Description
Deep Dry Needling into the site of the latent TriggerPoint of the upper trapezius muscle. 1 session in upper trapezius muscle moving the needle up and down ten times.
Intervention Type
Device
Intervention Name(s)
Control-Dry Needling
Intervention Description
Sham Dry Needling into the site of the latent Trigger Point of the upper trapezius muscle with non-penetrating needles
Primary Outcome Measure Information:
Title
Changes in resting surface EMG activity (amplitude, RMS)
Description
EMG activity (RMS) of the upper trapezius after dry needling or sham needling as assessed by the EMG ME 6000 TE(Mega Electronics, Kuopio, Finland). Resting EMG activity will be expressed as a percentage of maximal reference contractions of the upper trapezius (% reference contractions).
Time Frame
Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment
Secondary Outcome Measure Information:
Title
Changes in resting surface EMG activity (Median frequency, MF)
Description
EMG activity (RMS) of the upper trapezius after dry needling or sham needling as assessed by the EMG ME 6000 TE(Mega Electronics, Kuopio, Finland).
EMG median frequency will be used to determine the endurance of the upper trapezius. The EMG median frequency will be measured in Hertz (Hz).
Time Frame
Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment
Title
Changes in submaximal contrations surface EMG activity of upper trapezius (amplitude, RMS)
Description
EMG activity (RMS) of the upper trapezius after dry needling or sham needling as assessed by the EMG ME 6000 TE(Mega Electronics, Kuopio, Finland).
EMG activity of submaximal contractions will be expressed as a percentage of submaximal reference contractions of the upper trapezius (% reference contractions).
Time Frame
Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 7submaximal contractions EMG activity will be expressed as a percentage of maximal reference contractions of the upper trapezius (% reference contractions).2 hours after treatment
Title
Changes in submaximal contrations surface EMG activity of upper trapezius (Median frequency, MF)
Description
EMG activity (RMS) of the upper trapezius after dry needling or sham needling as assessed by the EMG ME 6000 TE(Mega Electronics, Kuopio, Finland).
EMG median frequency will be used to determine the endurance of the upper trapezius. The EMG median frequency will be measured in Hertz (Hz).
Time Frame
Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment
Title
Change in Pain Pressure Threshold (PPT)
Description
Pressure-Pain Threshold as assessed by an manual mechanical algometer. PPT is the minimal amount of pressure that produces pain and is used to assess abnormalities in nociceptive processing or hyperalgesia.
Time Frame
Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
30 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Age between 18 and 30 years
The presence of LTrP in the middle third of the upper trapezius muscle onthe dominant side
Being able to provide written informed consent
Being able to follow instructions and realize clinical tests
Exclusion Criteria:
Any pharmacological therapeutic
Any medical treatment or physical therapies at cervical region during the 6-month before this study
Any diagnosed health problem
Any history of head and upper extremity surgery or trauma
Any red flags to DN, (ie: metabolic diseases, pregnancy, kinesiophobia,Infection, cancer)• Absence of recurrent history of neck pain
No neck pain symptomatology the previous 6 months
Cervical disk herniation
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Javier Abián-Vicén, PhD
Organizational Affiliation
University of Castilla-La Mancha
Official's Role
Study Director
Facility Information:
Facility Name
Performance and Sport Rehabilitation Laboratory
City
Toledo
ZIP/Postal Code
45071
Country
Spain
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Effect of Dry Needling on Surface Electromyographic Activity in Latent Trigger Points
We'll reach out to this number within 24 hrs